Shares of IXICO plc (LON:IXI – Get Free Report) traded up 16.1% during mid-day trading on Tuesday. The company traded as high as GBX 9.50 and last traded at GBX 9. 1,314,879 shares were traded during trading, an increase of 1,210% from the average session volume of 100,369 shares. The stock had previously closed at GBX 7.75.
IXICO Trading Up 15.1%
The company has a quick ratio of 4.90, a current ratio of 2.83 and a debt-to-equity ratio of 5.22. The company has a 50-day moving average price of GBX 7.73 and a 200-day moving average price of GBX 7.87. The company has a market capitalization of £21.68 million, a price-to-earnings ratio of -5.08, a P/E/G ratio of -0.38 and a beta of 0.11.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
See Also
- Five stocks we like better than IXICO
- Are RTX Corporation and Northrop Grumman Ready to Break Out?
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
